Technology Lecture on Organ Printing: Promises and Challenges

Date: 05 Jun 2008 - 05 Jun 2008

Venue: SIMTech Training Room 1, Level 3, Tower Block

Organ printing or biomedical application of rapid prototyping, also defined as additive layer-by-layer biomanufacturing, is an emerging transforming technology that has potential for surpassing traditional solid scaffold-based tissue engineering. Organ printing has certain advantages: it is an automated approach that offers a pathway for scalable reproducible mass production of tissue engineered products; it allows a precise simultaneous 3D positioning of several cell types; it enables creation tissue with a high level of cell density; it can solve the problem of vascularisation in thick tissue constructs; finally, organ printing can be done in situ. The ultimate goal of organ-printing technology is to fabricate 3D vascularised functional living human organs suitable for clinical implantation. The main practical outcomes of organ-printing technology are industrial scalable robotic biofabrication of complex human tissues and organs, automated tissue-based in vitro assays for clinical diagnostics, drug discovery and drug toxicity, and complex in vitro models of human diseases. This presentation highlights the conceptual framework and recent developments in organ-printing technology, outlines main technological barriers and challenges, and presents potential future practical applications.

About the Speaker
Dr Vladimir Mironov is an Associate Professor at the Department of Cell Biology and Anatomy at the Medical University of South Carolina and Director of Bioprinting Research Center funded by prestigious $5 mln National Science Foundation "Frontiers in Intergrative Biological Research" grant.
Born in Russia, Dr Mironov graduated from the Ivanovo State Medical Institute in Russia with a masters degree and obtained his doctorate degree in Developmental Biology at the Second Moscow Pirogov Medical Institute in Moscow. He was trained in vascular biology at Professor Werner Risau's Vascular Biology Laboratory at the Max Planck Institute, Martinsried in Germany. He has published 150 peer-reviewed papers and several books.  His research fields encompass cardiovascular developmental biology and cardiovascular tissue engineering, organ printing and bioprinting. He hold 3 patents. Dr Mironov is a member of editorial boards of 3 journals. 
Dr Mironov is a co-founder of two biotech companies and consultant of several stem cells, tissue engineering and regenerative medicine US companies. He is also the co-founder and Vice-President of The World Academy for Bioprinting. He is frequently invited to present his talks by leading biotech and biomedical devices companies such as Amgen Inc. and Johnson and Johnson.

 9.30 am Registration
10.00am Presentation and Q&A 
11.30am Refreshments and Networking

Who Should Attend
This presentation is highly recommended for medical device manufacturers, professionals responsible for design and development, R&D and those who are new to the field.
Pre-registration for the lecture is necessary. Free admission. Seats are available on a first-come, first-served basis. All are welcome.   

For technical enquiries, please contact
Dr Leong Wai Yie, Email:
Dr Wiria Florencia Edith, Email:

For general enquiries, please contact 
Alice Koh, Email: